0001104659-23-095016.txt : 20230824 0001104659-23-095016.hdr.sgml : 20230824 20230824214822 ACCESSION NUMBER: 0001104659-23-095016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seizinger Bernd R. CENTRAL INDEX KEY: 0001789042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 231203701 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 FORMER NAME: FORMER CONFORMED NAME: Seizinger Bernd DATE OF NAME CHANGE: 20190923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 267-370-5219 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 4 1 tm2324788-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-23 0 0001781983 Aprea Therapeutics, Inc. APRE 0001789042 Seizinger Bernd R. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 1 0 0 0 0 Common Stock 2023-08-23 4 A 0 500 0.00 A 26825 D Stock Options (Right to Buy) 3.65 2023-08-23 4 A 0 2000 0.00 A 2033-08-23 Common Stock 2000 2000 D These shares represent restricted stock units which were granted on August 23, 2023, and which will vest and be settled in common stock on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. The option vests in full on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. /s/ John Hamill, as Attorney-in-Fact 2023-08-24